|
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between The New York Academy of Sciences and the Josiah Macy, Jr. Foundation.
This Initiative has enabled the formation of the Translational Medicine Discussion Group. This interdisciplinary Group provides a unique, recurring forum that unites physicians with basic researchers, industry and academic scientists, public health experts, and others to spark an interdisciplinary and scholarly discussion of recent breakthroughs and remaining challenges in translating basic science into clinical applications. Discussions will catalyze innovation regarding how to better integrate the teaching of basic, cutting-edge science in medical education, in addition to examining diseases and pathologies present in urban environments in a unique and interdisciplinary manner.
To learn about the latest advances in the translation of basic research into clinical application, join us at an upcoming meeting or see our unique library of Publications and Multimedia below.
Translational Medicine Initiative: Career Development
An ongoing mission of the Academy's Science Alliance program is to build a consortium of universities, teaching hospitals, and independent research facilities committed to advancing the careers of students and postdocs across multiple institutions and disciplines.
The Josiah Macy, Jr. Foundation also provided funds to sponsor a limited number of free, one-year student memberships to the New York Academy of Sciences. All of the slots under this membership offer have now been filled and we can no longer accept new members. If you are interested in Academy membership, please visit the Member Center to learn more about membership and to join. Presented by
The Josiah Macy, Jr. Foundation is a privately endowed philanthropy dedicated to supporting programs designed to broaden and improve the education of and collaboration among medical and health care professionals.
Upcoming Initiative Events
Thursday, June 6, 2013 | 8:30 AM - 6:30 PM
Organizers: Sharon Akabas (Columbia University), Gerald Friedman (The Mount Sinai Hospital), Martin Kohlmeier (University of North Carolina), Charlotte Pratt (National Institute of Health), Gwen Twillman (American Society for Nutrition), Mandana Arabi (The Sackler Institute for Nutrition Science), Brooke Grindlinger (The New York Academy of Sciences)
This conference aims to revisit the current nutrition curricula for health professionals and to explore how trainings can better provide the skills necessary for implementing the array of preventative and therapeutic nutrition interventions available. Presented as part of the Translational Medicine Initiative.
Past Initiative Events
Friday, March 22, 2013 | 7:45 AM - 6:00 PM
Speakers: Jessica S. Ancker (Weill Medical College of Cornell University), Barbara Barry (Northeastern University), Herbert Chase (Columbia University), Curtis M. Coomes (RTI International), Humberto Cruz (New York State Department of Health AIDS Institute), Michael C. Gibbons (Johns Hopkins Urban Health Institute), Miguel Gomez (US Department of Health and Human Services / AIDS.gov), Martin S. Kohn (IBM Thomas J. Watson Research Center), Joseph C. Kvedar (Center for Connected Health, Partners Healthcare), Debra A. Lieberman (University of California, Santa Barbara), Roberto Martinez (New York State Department of Health), Deven McGraw (Center for Democracy & Technology), John O. Moore (MIT Media Lab), Jean-Luc Neptune (Health 2.0 LLC), William Rodriguez (Daktari Diagnostics, Inc.), Stephen C. Schoenbaum (The Josiah Macy Jr. Foundation), Iana Simeonov (University of California, San Francisco), George E. Thibault (The Josiah Macy Jr. Foundation), Marc M. Triola (NYU School of Medicine), Jennifer D. Uhrig (RTI International)
Explore the impact of digital technologies on clinical care, especially for HIV and other sexually transmitted infections. Speakers will discuss eHealth strategies and tools for patient-centered care, provider communications, clinical decision support, medical education, and research.
Tuesday, October 2, 2012 | 8:15 AM - 5:15 PM
Organizers: Fritz François (NYU School of Medicine), Mekbib Gemeda (NYU Langone Medical Center), Jo Wiederhorn (Associated Medical Schools of New York)
Explore ways in which to incorporate health disparities research and preventative care approaches into the medical school curriculum, attract trainees to partake in health inequity research, and improve the recruitment of minority medical students.
Tuesday, May 15, 2012 | 12:00 PM - 5:00 PM
Organizers: Eyal Talor (CEL-SCI Corporation), George Zavoico (MLV), Jennifer Henry (The New York Academy of Sciences)
Speakers: Francesco Marincola (National Institutes of Health), Sangkon Oh (Institute of Immunology Research), Andrew T. Parsa (University of California, San Francisco), Rachel L. Sabado (NYU Langone Medical Center), Eyal Talor (CEL-SCI Corporation), and John S. Yu (Cedars-Sinai Medical Center and Immunocellular Therapeutics, Ltd.)
Cancer vaccines target specific tumor antigens yet spare the immune suppressive effects of radiation and chemotherapy. This symposium reviews the current approaches in cancer immunotherapy, immunomodulation, and highlights emerging cancer vaccines.
Friday, February 24, 2012 | 8:15 AM - 7:30 PM
Organizers: Erica Friedman, David Muller and Karen Zier (Mount Sinai School of Medicine)
Opening Remarks: George Thibault (The Josiah Macy Jr. Foundation)
This conference will discuss benefits, such as improved analytic, creative, and critical-thinking skills and practical issues of implementing mandatory research training for all medical students.
December 1 - 3, 2011
Organizers: Gregory J. del Zoppo (University of Washington School of Medicine), Andrei V. Alexandrov (University of Alabama at Birmingham)
Presented as part of the Translational Medicine Initiative, this 2.5-day conference will explore the state-of-the-art and future directions of research and clinical practice leading to enhanced medical care in the acute treatment of ischemic stroke.
Tuesday, March 29, 2011 | 1:00 PM - 5:00 PM
Organizers: Lorrence H. Green (Westbury Diagnostics) and Jennifer Henry (The New York Academy of Sciences)
Routine blood screening protocols test for several common pathogens, but miss others such as XMRV. This symposium will discuss recent advances in the testing and screening of the blood supply as well as suggestions for future directions. Presented as part of the Translational Medicine Initiative.
March 9 - 11, 2011
Organizers: Stephen Marder (University of California, Los Angeles School of Medicine), Bita Moghaddam (University of Pittsburgh) and Bryan Roth (University of North Carolina School of Medicine)
This conference will facilitate the translation of discoveries in basic neuroscience into the development of innovative pharmacological agents for the treatment of schizophrenia by convening and encouraging dialogue among clinical, translational and basic neuroscientists. Presented as part of the Translational Medicine Initiative.
Thursday, February 10, 2011 | 1:00 PM - 5:00 PM
Speakers: Michael B. Sporn (Dartmouth Medical School), Elizabeth A. Grimm (MD Anderson Cancer Center), Dmitry Gabrilovich (H. Lee Moffitt Cancer Center), Colin Meyer (Reata Pharmaceuticals, Inc.) and Stephen T. Sonis (Harvard/Farber Cancer Center)
Reactive oxygen and nitrogen species (RONS) are implicated in cancer and inflammation pathogenesis. This symposium covers the mechanisms that regulate their generation and metabolism, their role in disease, and the development of novel therapeutics. Presented as part of the Translational Medicine Initiative.
Tuesday, January 25, 2011 | 1:00 PM - 5:00 PM
Speakers: Per Gjorstrup (Resolvyx Pharmaceuticals), Karsten Gronert (University of California, Berkeley), Mauro Perretti (Queen Mary University of London), Charles N. Serhan (Harvard University, Brigham & Women's Hospital), Ira Tabas (Columbia University), and Edward Thorp (Columbia University)
Chronic inflammation contributes to the progression of many common diseases. This symposium reviews advances in treating chronic inflammatory diseases by promoting active resolution of inflammation instead of only blocking proinflammatory mediators. Presented as part of the Translational Medicine Initiative.
Tuesday, November 16, 2010 | 1:00 PM - 5:00 PM
Speakers: Greg Hannon (Cold Spring Harbor Laboratory), Pier Paolo Pandolfi (Harvard Medical School), John Rinn (Harvard Medical School), Ramin Shiekhattar (The Wistar Institute), David Spector (Cold Spring Harbor Laboratory)
Non- coding RNAs are emerging as important regulators of development and function in many physiological processes. Their role in controlling pathogenesis and their potential as targets for therapeutic intervention are becoming increasingly apparent. Presented as part of the Translational Medicine Initiative.
Tuesday, September 28, 2010 | 1:00 PM - 5:00 PM
Speakers: Fadi G. Akar (Mount Sinai School of Medicine), Roger J. Hajjar (Mount Sinai School of Medicine), Walter J. Koch (Thomas Jefferson University), and Evangelia Kranias (University of Cincinnati College of Medicine)
Development of therapies to treat heart failure is hampered by a lack of understanding of underlying mechanisms. This symposium reviews current and potential therapeutic approaches, and research to identify useful molecular targets. Presented as part of the Translational Medicine Initiative.
Wednesday, June 23, 2010 | 8:15 AM - 5:30 PM
Despite vast advances in biomedical research and technology, the medical school curriculum has remained mostly static for the past half century. This goal of this conference is to highlight innovative new models for physician training motivated by advances in science and technology, and to consider how to more closely link basic science and clinical training. Presented as part of the Translational Medicine Initiative.
Monday, May 24, 2010 | 1:00 PM - 5:30 PM
Organizers: Doris Bucher (New York Medical College), Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium will revisit the 2009 outbreak and examine strategies against future outbreaks. Presented as part of the Translational Medicine Initiative.
Initiative Publications
Multimedia eBriefings
Access expert online multimedia reports of Academy events with Academy eBriefings.
December 4, 2012
Organizers: Fritz François (New York University School of Medicine), Mekbib Gemeda (New York University Langone Medical Center), Jo Wiederhorn (Associated Medical Schools of New York), Sonya Dougal (The New York Academy of Sciences), and Brooke Grindlinger (The New York Academy of Sciences)
A young single mother in a low income neighborhood who must make five bus transfers to reach her primary care physician; a family in rural New Mexico that lacks access to healthy food; a doctor who, after explaining the importance of taking insulin several times, doesn't understand why a patient's diabetes isn't under control—these are just some scenarios that contribute to health disparities in the United States.
May 1, 2012
Organizers: Erica Friedman, David Muller, and Karen Zier (Mount Sinai School of Medicine) & Sonya Dougal and Monica Kerr (The New York Academy of Sciences)
Laboratory experimentation has been included in physician training since at least 1839 when Yale University first incorporated a research thesis into its medical school graduation requirements. While Yale has maintained that curricular requirement ever since, and many other medical schools have incorporated research programs, conducting research is not universally required to earn an MD.
May 1, 2012
Moderator: Karen Zier (Mount Sinai School of Medicine)
Panelists: Don Hoang (Yale University School of Medicine), Samuel Vanderhoek (Mount Sinai School of Medicine), Edward Vazquez (New York Presbyterian Hospital–Columbia Campus), and Annie Wang (The Warren Alpert Medical School of Brown University)
Some medical school educators say that undertaking basic research can help medical school students sharpen the analytical, creative, and critical-thinking skills that the practice of medicine demands. And in the contemporary environment of rapidly advancing science, uniting medical education with scientific research is seen as a crucial way to ensure that scientific discoveries are translated to clinical practice as expediently as possible. Exposing medical students to research might also lead some to consider career paths that include investigation—historically a rarity among medical school graduates.
February 3, 2011
Organizers: Senthil K. Muthuswamy (Cold Spring Harbor Laboratory and Ontario Cancer Institute), Pier Paolo Pandolfi (Harvard Medical School), and Jennifer Henry (The New York Academy of Sciences).
Small RNAs do not code for proteins, but they nonetheless have an important role to play in the regulation of the development and execution of many cellular processes crucial to overall physiological well-being. Scientists are increasingly aware of these molecules' part in controlling disease pathogenesis and of their potential as targets for therapeutic intervention. At a November 16, 2010 symposium called Non-coding RNAs in Oncogenesis researchers gathered at The New York Academy of Sciences to explore the role of non-coding RNAs in oncogenesis, focusing on how they affect methylation patterns or interact with messenger RNAs to regulate gene expression, the role they play in cellular differentiation, and how they bind proteins to modulate protein function.
November 1, 2010
Organizers: Charles A. Lunn (Merck Research Laboratories), Martin A. Schwarz (Mount Sinai School of Medicine), and Jennifer Henry (New York Academy of Sciences)
Development of therapies to treat heart failure is hampered by a lack of understanding of underlying mechanisms. This symposium reviews current and potential therapeutic approaches, and research to identify useful molecular targets.
September 14, 2010
Despite vast advances in biomedical research and technology, the medical school curriculum has remained mostly static for the past half century. The goal of this conference was to highlight innovative new models for physician training motivated by advances in science and technology, and to consider how to more closely link basic science and clinical training.
July 23, 2010
Organizers: Doris Bucher (New York Medical College) and Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium revisited the 2009 outbreak and examined strategies against future outbreaks.
~~~~~~~~~~~~
Volume 1205 S1, September 2010
Volume 1205 S1, September 2010
This collection of meeting reports includes scholarly summaries of two discussion groups that took place at the New York Academy of Sciences, "HIV/AIDS: Vaccines and Alternative Strategies for Treatment and Prevention" and "H1N1 Swine Flu: The 2010 Perspective"
~~~~~~~~~~~~
Podcasts
March 14, 2013
Dr. Joseph Kvedar, Founder and Director of the Center for Connected Health, Dr. Martin Kohn, Chief Medical Scientist for Health Care Delivery at IBM Research, and Dr. Marc Triola, Associate Dean for Educational Informatics at NYU School of Medicine and Director of the Division of Educational Informatics, discuss the emerging roles of digital technology in healthcare.
March 26, 2012
You've heard it once, you've heard it a thousand times: the U.S. has a big problem with obesity. But did you know that there are demonstrated links between obesity and all kinds of serious health problems—including cancer? In this episode, Science & the City explores the obesity-cancer connection.
September 2, 2011
Heart disease is the leading death for Americans today. In this special edition of the Science & the City podcast, hear what Dr. Valentin Fuster, director of the Wiener Cardiovascular Institute at the Mount Sinai School of Medicine, and scientific organizer of the Academy's upcoming conference on cardiovascular health in Barcelona, Spain, has to say about heart healthy behavior in children, youth, and adults.
April 14, 2011
Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.
September 24, 2010
Three experts who spoke at a recent Academy conference discuss what personalized medicine is, the technology behind it, and how it will change the patient's experience.
Other Related Events in Translational Research and Medicine
Wednesday, June 5, 2013 | 12:00 PM - 4:00 PM
Keynote Speaker: Alanna Schepartz (Yale University)
Speakers: Han Guo (Luo lab, Memorial Sloan–Kettering Cancer Center), Rudy Jacquet (Montclare lab, NYU-Poly), Neel Shah (Muir lab, Princeton University), Monika Raj (Arora lab, NYU), Wenjiao Song (Jaffrey lab, Weill Medical College, Cornell University), and Carola Wilczek (Shechter lab, Albert Einstein College of Medicine)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Professor Alanna Schepartz of Yale University and a poster session.
Thursday, June 6, 2013 | 8:30 AM - 6:30 PM
Organizers: Sharon Akabas (Columbia University), Gerald Friedman (The Mount Sinai Hospital), Martin Kohlmeier (University of North Carolina), Charlotte Pratt (National Institute of Health), Gwen Twillman (American Society for Nutrition), Mandana Arabi (The Sackler Institute for Nutrition Science), Brooke Grindlinger (The New York Academy of Sciences)
This conference aims to revisit the current nutrition curricula for health professionals and to explore how trainings can better provide the skills necessary for implementing the array of preventative and therapeutic nutrition interventions available. Presented as part of the Translational Medicine Initiative.
June 19 - 20, 2013
Conference Planning Committee: Claudio Carini (Pfizer Inc.), Teresa Compton (Biogen Idec (Conference Chair)), Marion Kasaian (Pfizer Inc.), Theodora Salcedo (Bristol-Myers Squibb Company), Anne Vogt (F. Hoffmann-La Roche Ltd)
Scientific Advisory Board: Leonard Calabrese (Cleveland Clinic), Paola Cinque (Hospital San Raffaele), David Clifford (Washington University School of Medicine), Robert Garcea (University of Colorado at Boulder), Eugene Major (National Institute of Neurological Disorders and Stroke), Kenneth Tyler (University of Colorado Anschutz Medical Campus), Thomas Weber (University of Hamburg)
New basic science and clinical findings relevant to the pathogenesis, mitigation, cure, and risk stratification of Progressive Multifocal Leukoencephalopathy will support a discussion of current challenges and future directions for PML treatment.
Monday, June 24, 2013 | 10:30 AM - 3:00 PM
Speakers: Yasmine Belkaid (National Institute of Allergy and Infectious Diseases, NIH), Dan R. Littman (New York University School of Medicine), Alexander Rudensky (Memorial Sloan-Kettering Cancer Center)
The Ross Prize, established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine, is awarded to an investigator producing innovative, paradigm-shifting research worthy of significant attention in molecular medicine.
Wednesday, September 18, 2013 | 5:00 PM - 6:45 PM
Moderator: Orla M. Smith (Science Translational Medicine)
Panelists: Amanda Boxtel (Ekso Bionics), Grégoire Courtine (Swiss Federal Institute of Technology, EPFL), Nathan Harding (Ekso Bionics)
Join us for a discussion of cutting-edge technologies that may revolutionize spinal cord injury rehabilitation and treatment. Included in the discussion is a live demonstration of a wearable robot (or exoskeleton) that enables people with lower-extremity paralysis or weakness to stand and walk. We will present perspectives from an innovator, a researcher, and a patient, who will share their insights on how these new technologies benefit the public now and in the future to come.
September 18 - 20, 2013
Explore innovative models for advancing the translation of novel neurotechnologies, such as neurostimulation, brain-computer interfaces, and neuron replacement therapies, into diagnostic tools and treatments for neurological and psychiatric disease.
Tuesday, September 24, 2013 | 8:30 AM - 4:30 PM
Speakers: Elena V. Galkina (Eastern Virginia Medical School), Emmanuel L. Gautier (Washington University School of Medicine, St. Louis), Klaus Ley (La Jolla Institute for Allergy and Immunology), Andrew H. Lichtman (Brigham and Women's Hospital, Harvard Medical School), Kathryn J. Moore (New York University Medical Center), Matthias Nahrendorf (Harvard Medical School), Alan R. Tall (Columbia University Medical Center)
Currently available therapies fail to resolve the full burden of many cardiovascular diseases. Understanding the role of key hematopoietic and inflammatory players in this disease process may help identify new targets for fighting atherosclerosis.
Friday, October 4, 2013 | 8:30 AM - 4:30 PM
Speakers: David Artis (University of Pennsylvania), Stephen M. Collins (McMaster University), Michael A. Fischbach (University of California, San Francisco), Dirk Gevers (The Broad Institute of MIT and Harvard), Jeremy K. Nicholson (Imperial College London), Lita M. Proctor (National Human Genome Research Institute, NIH)
Symbioses between humans and our gut microbiome influence human biology including nutrition, immune function, and brain development. We review how symbiotic relationships impact drug metabolism and development, and a variety of disease states. This symposium features a poster session.
Tuesday, October 22, 2013 | 8:30 AM - 4:30 PM
Speakers: Yasmina Bauer (Actelion Pharmaceuticals Ltd), Jeremy S. Duffield (University of Washington), Raghu Kalluri (The University of Texas MD Anderson Cancer Center), Marco Prunotto (F. Hoffmann-La Roche), Richard M. Silver (Medical University of South Carolina), Dianqing (Dan) Wu (Yale University)
Fibrosis is common in chronic organ injury, leading to progressive life-threatening outcomes. We review the link between fibrosis and disease and explore ways to use biomarkers and imaging to translate laboratory results into clinical success.
Monday, November 4, 2013 | 8:30 AM - 4:30 PM
Speakers: Anirban Banerjee (National Institute of Child Health and Human Development, NIH), Carole A. Bewley (National Institute of Diabetes and Digestive and Kidney Diseases, NIH), Bryan Fry (The University of Queensland, Australia), Mandë Holford (Hunter College, CUNY / American Museum of Natural History), Baldomero M. Olivera (University of Utah), Beatrix Ueberheide (New York University)
Snakes, scorpions, sea snails and leeches produce over 10 million compounds offering great potential for venom-based drug discovery. This symposium investigates genomic, proteomic, and transcriptomic approaches to harness venom compounds.
November 6 - 7, 2013
NIA Technical Advisor: Neil Buckholtz (National Institute on Aging)
Organizers: Alan Cross (AstraZeneca), Sonya Dougal (The New York Academy of Sciences), Howard Feldman (University of British Columbia), Surya Kolluri (Bank of America), Ian Kremer (Leaders Engaged on Alzheimer's Disease), Tetsuyuki Maruyama (Takeda), Richard C. Mohs (Eli Lilly and Company), Jeffrey S. Nye (Janssen R&D), Ronald C. Petersen (Mayo Clinic), Gregory A. Petsko (Weill Cornell Medical College), Andrea Pfeifer (AC Immune), Thomas Rooney (Sanofi), Darryle D. Schoepp (Merck and Company, Inc.), Diane Stephenson (Critical Path Institute), Rudolph E. Tanzi (Harvard Medical School), John Q. Trojanowski (University of Pennsylvania), Diana L. van de Hoef (The New York Academy of Sciences), George Vradenburg (The Global CEO Initiative on Alzheimer's Disease), Michael Weiner (University of California, San Francisco)
This conference will convene leading industry, academic, and government stakeholders to discuss how to prevent and effectively treat Alzheimer's by 2025, by coordinating with governmental efforts to build research resources, reengineer our current drug development and evaluation systems, and identify innovative technologies and financing models. The outcome of this meeting will comprise a research agenda that will delineate the pathways needed to effectively treat and prevent Alzheimer's disease by 2025.
Tuesday, December 10, 2013 | 8:30 AM - 4:30 PM
Speakers: Frank M. LaFerla (University of California, Irvine), Sylvain E. Lesné (University of Minnesota), Bingwei Lu (Stanford University School of Medicine), Lennart Mucke (Gladstone Institute of Neurological Disease), Franck Polleux (The Scripps Research Institute), Terrence Town (University of Southern California), Ralph A. Nixon (Nathan Kline Institute)
Organizers: Ken Jones (Forest Research Institute), Robert Martone (Covance Biomarker Center of Excellence), Robert B. Nelson (Lundbeck Research USA), Jennifer Henry (The New York Academy of Sciences)
This symposium explores how efforts to better integrate our understanding of neuritic plaques and neurofibrillary tangles—the two hallmark pathologies of Alzheimer's disease—are leading to a 'truce' between former rivals in the quest for therapies.
Other Publications in Translational Research and Medicine
Webcasts
November 17, 2010
Speakers: Barbara M. Alving (NIH), ShaAvhree Buckman (FDA Center for Drug Evaluation and Research), Garret A. FitzGerald (University of Pennsylvania), Ruth E. March (AstraZeneca), Laura K. Richman (R&D Translational Science) and Orla Smith (Science Translational Medicine)
This November, MedImmune and the New York Academy of Sciences are co-hosting a press forum to explore the critical role of Translational Science to future therapeutic breakthroughs and to the personalization of medicine (with a focus in oncology, but also including other disciplines such as inflammatory or cardiovascular disease).
View Archived Webcast
~~~~~~~~~~~~
Multimedia eBriefings
Access expert online multimedia reports of Academy events with Academy eBriefings.
November 1, 2010
Organizers: Charles A. Lunn (Merck Research Laboratories), Martin A. Schwarz (Mount Sinai School of Medicine), and Jennifer Henry (New York Academy of Sciences)
Development of therapies to treat heart failure is hampered by a lack of understanding of underlying mechanisms. This symposium reviews current and potential therapeutic approaches, and research to identify useful molecular targets.
September 14, 2010
Despite vast advances in biomedical research and technology, the medical school curriculum has remained mostly static for the past half century. The goal of this conference was to highlight innovative new models for physician training motivated by advances in science and technology, and to consider how to more closely link basic science and clinical training.
July 23, 2010
Organizers: Doris Bucher (New York Medical College) and Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium revisited the 2009 outbreak and examined strategies against future outbreaks.
April 5, 2010
Organizer: Vincent P. Tomaselli (Center for Advanced Information Management, Columbia University)
The switch to electronic health records promises to save money, improve patient care, and facilitate information sharing. But implementation is expensive and privacy concerns remain. A recent Academy conference addressed all these issues.
~~~~~~~~~~~~
Volume 1189, issue S1, March 2010
This Annals online meeting report presents an summary of the "Fourth Annual Translational Stem Cell Research Conference: Breaking Ground", sponsored by the New York Stem Cell Foundation.
Edited by Raymond P. Donnelly (Center for Drug Evaluation & Research (CDER), Food and Drug Administration, Rockville, Maryland) Volume 1182, December 2009
This volume includes presentations by experts from academia, industry and government on the scientific and clinical basis for the successes and failures of recombinant cytokines and cytokine antagonists as therapeutic agents.
Edited by Ralph Steinman (The Rockefeller University, New York, New York), Jacques Banchereau (Baylor Institute for Immunology Research, Dallas, Texas), and Olivera J. Finn (School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania) Volume 1174, September 2009
From world-renowned researchers and clinicians, manuscripts in this volume shed light on recent steps forward in immunotherapeutic and preventive approaches for future cancer vaccines.
|
|